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Abstract
Background: When analyzing microarray data a primary objective is often to find differentially
expressed genes. With empirical Bayes and penalized t-tests the sample variances are adjusted
towards a global estimate, producing more stable results compared to ordinary t-tests. However,
for Affymetrix type data a clear dependency between variability and intensity-level generally exists,
even for logged intensities, most clearly for data at the probe level but also for probe-set
summarizes such as the MAS5 expression index. As a consequence, adjustment towards a global
estimate results in an intensity-level dependent false positive rate.
Results: We propose two new methods for finding differentially expressed genes, Probe level
Locally moderated Weighted median-t (PLW) and Locally Moderated Weighted-t (LMW). Both
methods use an empirical Bayes model taking the dependency between variability and intensity-
level into account. A global covariance matrix is also used allowing for differing variances between
arrays as well as array-to-array correlations. PLW is specially designed for Affymetrix type arrays
(or other multiple-probe arrays). Instead of making inference on probe-set summaries,
comparisons are made separately for each perfect-match probe and are then summarized into one
score for the probe-set.
Conclusion: The proposed methods are compared to 14 existing methods using five spike-in data
sets. For RMA and GCRMA processed data, PLW has the most accurate ranking of regulated genes
in four out of the five data sets, and LMW consistently performs better than all examined
moderated t-tests when used on RMA, GCRMA, and MAS5 expression indexes.
Background
Microarrays are widely used for measuring gene expres-
sion in biomedical research. For the purpose of finding
differentially expressed genes there exist numerous meth-
ods. In early studies genes where often ranked with respect
to fold-change. Genes showing fold-change above 2 (or 3)
were regarded as potentially regulated and were selected
for further investigation. The obvious drawback with such
an approach, as pointed out by many authors, is that
genes with high fold-change may also be highly variable
and thus with low significance of the regulation. On the
other hand, since the number of replicates in many stud-
ies is small, variance estimators computed solely within
genes are not reliable in that very small values can occur
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from low power and is not a better option for filtering out
regulated genes.
Many methods have been proposed to improve on the
variance estimator in order to find more powerful statisti-
cal tests for differential expression. In empirical Bayes
methods [1-8] and the penalized t-test suggested in [9],
the gene-specific variance estimator is modified in order
to produce more stable results. With proportions deter-
mined by the accuracy of the gene-specific variance esti-
mators, a mixture of the gene-specific variance estimator
and a global variance estimate is used in place of the gene-
specific variance estimator in the denominator of the t-
test. Similarly, in the Significance Analysis of Microarrays
(SAM) method [10] and the method suggested in [11], a
constant is added to the gene-specific sample standard
deviation.
Another approach is to pool variance estimators for genes
having similar expression level, thus modeling the vari-
ance as a function of intensity-level. For example Eaves et
al. [12] use a weighted average of the gene-specific vari-
ance estimator and a pooled estimate based on the 500
genes with most similar mean expression level, and Jain et
al. [13] suggest the local-pooled-error method (LPE)
where a variance function fitted to estimated variances
and mean intensities is used. Comander et al. [14] pool
genes with respect to minimum intensity rather than
mean intensity, and Hu et al. [15] use a hierarchical
model with a linear relationship between variance and
intensity-level. Of these four methods, only the one sug-
gested in [15] takes the accuracy of the gene-specific vari-
ance estimators into account when setting the weights for
the gene-specific estimator and the pooled estimator,
respectively. On the other hand Hu et al. [15] only deal
with a linear relationship between variance and intensity-
level. A variance to intensity-level dependency is also uti-
lized in the moderated t-test suggested in [6]. The method
proposed builds on the moderated t-test suggested in
[2,3] with the addition of fitting a loess curve in the scatter
plot of logged variance estimators against mean intensity
when estimating the model parameters.
The type of arrays considered in this paper is the Affyme-
trix GeneChip arrays. These arrays are one color arrays and
each gene is represented by a set of probes, the probe-set,
consisting of 10–16 probe-pairs. Each probe-pair consists
of one perfect match (PM) probe and one mismatch
(MM) probe. The probes are 25 bases long and the PM
and MM probes have identical sequences of bases except
for the middle probe which in the MM probe is set to the
complementary base of that in the PM probe. The MM
probes are thus designed to measure the background
intensity for the corresponding PM probe. The standard
way of dealing with the multiple-probes is to derive a
probe set summary, an expression index, for each probe-
set (gene) and array (sample), for example using the RMA
method [16] or the Affymetrix MAS5 algorithm. The
expression indexes are then used in downstream analysis
by only considering the expression index itself, the preci-
sion of the expression index is ignored. However, in the
fully Bayesian probe-level BGX model [17] information
about the accuracy of the expression index is obtained as
a complete distribution which is subsequently used when
computing the posterior distribution of differential
expression. Also, the probe-level measurement error from
the probabilistic probe-level model multi-mgMOS [18] is
used when computing the probability of positive log-ratio
in the PPLR method [19].
For Affymetrix type arrays a dependency between variabil-
ity and intensity-level generally exists, even for log-trans-
formed data. Figure 1 shows scatter plots of sample
variance versus sample mean calculated on logged PM
intensities (background corrected and normalized using
the default methods of RMA) and three different expres-
sion indexes: RMA, GCRMA and MAS5. Except for the
RMA expression index a clear dependency between varia-
bility and intensity-level exists, with a unique signature
for each type of pre-processing of the raw CEL-file data.
The GCRMA expression index shows increasing variability
with intensity-level while MAS5 shows the opposite rela-
tionship. As a consequence, methods assuming constant
variance as well as methods adjusting the gene-specific
variance (or standard deviation) estimators towards a glo-
bal estimate suffer from intensity-level dependent false
positive rates. Figure 2 shows an example where the mod-
erated t-test in the R-package LIMMA [3] was used on
MAS5 expression indexes computed on a set of replicated
arrays. The false positive rate obtained with LIMMA fol-
lows the same pattern as in the right lower panel in Figure
1 where the same data set is used. Almost identical result
was obtained using data set A in a similar simulation (data
not shown).
The aim of variance stabilizing transformations is to
reduce or eliminate the problem of dependency between
variability and intensity-level. A family of transforma-
tions, the generalized-log family (glog), was introduced in
[20-22] and further used in [23,24]. A comparison of the
glog family with the started logarithm transformation
[25] and the log-linear hybrid transformation [26] is pre-
sented in [27]. It is concluded that the glog family is
"probably the best choice when it is convenient to use it",
but it is also noted that the direct interpretation of differ-
ences as logged ratios for microarray data when using the
ordinary log-transformation, does not hold when using
such variance stabilizing transformations.Page 2 of 11
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ance when applied to raw Affymetrix probe-level data, for
example using the parameter estimation procedure
described in [21]. However, the transformations implic-
itly defines a background correction, and when applied to
data already having been subject to another background
correction (or further processed data), the glog transfor-
mations may not be able to capture the structure of the
dependency between variability and intensity-level. This
applies, for example, to probe-level data background cor-
rected using the RMA default background method, and
MAS5 expression indexes, see Figure 2. Thus, there is a
need for more flexible solutions, and in short, Figures 1
and 2 may be seen as one motivation for the methods pro-
posed in this paper.
The hierarchical Bayesian model WAME proposed and
developed in [4,5,7,8] is in the present paper extended to
incorporate the variability to intensity-level dependency.
The Probe level Locally moderated Weighted median-t
method (PLW) applies the extended model to logged PM
intensities resulting in moderated and weighted t-statistics
for all PM probes. In the final step of PLW the median t-
statistic of all PM probes building up each probe-set is
computed, and this median is the value used for ranking
the probe-sets with respect to differential expression.
The Locally Moderated Weighted-t method (LMW) is a
more general method intended for single probe type of
arrays or summary measures of multiple probe type
arrays, such as RMA and MAS5. LMW use the same model
as PLW but since only one t-statistic is obtained for each
probe-set no median is calculated. The proposed methods
Probe-, or probe-set, wise sample variances against sample meansFigure 1
Probe-, or probe-set, wise sample variances against 
sample means. Scatter plots of sample variance s2 (logged 
with base 2) against mean intensity for logged PM intensities 
and three expression indexes. Left and right panels show 
data set A and B, respectively (see Section Data sets).
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False positive rate against mean intensityigure 2
False positive rate against mean intensity. False posi-
tive rate (α) calculated on re-sampled data and plotted 
against mean intensity. 100 data sets of size 6 were sampled 
from the complete data set B (see Section Data sets) of 18 
replicated arrays and then analyzed using the Affymetrix 
MAS5 algorithm followed by a two group analysis of 3+3 
arrays using the moderated t-test in the R-package LIMMA 
[3], on logged MAS5 indexes and indexes transformed using 
the variance stabilizing transformation in the R-package vsn 
[21], and the proposed method LMW using logged MAS5 
indexes. false positive rate were obtained by averaging over 
the sampled data sets using loess-curves fitted to mean inten-
sity and indicator of significance (1 if the probe-set is among 
the 5% probe-sets with highest absolute statistic, 0 other-
wise). The mean intensities of each data set are shifted to the 
range [0,15].
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available spike-in data sets.
Results and Discussion
Model and methodology
Given a set of n arrays let yip be the background corrected
and normalized log-intensity on array i for PM probe p
and put yp = (y1p,...,ynp)T. The PM probes are divided into G
(disjoint) probe-sets  and thus there are a total
of  probes. For p = 1,...,P assume
where μp is the log-intensity profile for probe p across the
n arrays with mean log-intensity level , ∑ is an n × n
covariance matrix, m is a real-valued parameter, and ν(·)
is a smooth real-valued function. Nn denotes an n-dimen-
sional normal distribution, and Γ-1(a, b) denotes the
inverse-gamma distribution with shape parameter a and
scale parameter b. A cubic spline is used to parameterize
the function ν(·). Given set of K interior spline-knots
ν(x) = exp{H(x)Tβ}
where β is a parameter vector of length 2K - 1 and H :  →
2K-1 is a set of B-spline basis functions, see chapter 5 of
[28].
As in the model suggested in [4] the model in Equ. 1
makes use of a global covariance matrix, thus allowing dif-
fering variances as well as correlations between arrays. To
account for the dependency between variability and inten-
sity-level the scale-parameter of the Γ-1-distribution
depends on the mean log-intensity level  for the probe
through the smooth function ν.
We assume that the vector μp is determined by a full rank
n × k design matrix D and a parameter vector γp of length
k. The aim is to estimate and test hypothesis for δp, a linear
combination of γp specified by a 1 × k matrix C. In sum-
mary,
μp = Dγp and δp = Cγp.
For the special case of comparing two conditions, with n1
and n2 arrays from conditions 1 and 2, respectively, the
design matrix D is an (n1 + n2) × 2 matrix. For example,
with n1 = 3 and n2 = 4 we can use
and thus μp = (γp1, γp1, γ p1, γp2, γp2, γp2, γp2)T. With C = [-1
1] we have δp = γp2 - γp1, thus δp is the logged fold change
between conditions 2 and 1.
However, instead of estimating the parameters of the
model in Equ. 1 we use a reduced model derived from
Equ. 1 through a linear transformation of the vector yp.
Define the n × n and n × 1 matrices
A0 = I - D(DT D)-1 DT and B = D(DT D)-1CT.
Since A0 is of rank n - k only we let A be an n × (n - k)
matrix whose column space equals that of A0.
With q = n - k + 1 form the n × q transformation matrix M
and the vector zp of length q
M = [A; B] and zp = MT yp (2)
giving the reduced model
where ∑z = MT∑M.
The reduced model is fitted using the EM algorithm [29]
as described in Section Parameter estimation.
The cp's are treated as missing data and we replace the
unknown intensity-level for probe p, , with the
observed mean intensity across arrays, . Given estima-
tors of the parameters ∑z, m, and β we proceed as if these
parameters are known, and weighted moderated t-tests are
computed for each probe p. The unbiased minimum vari-
ance estimator of δp is
where λ is the vector (0,...,0, 1)T of length q. The weighted
moderated t-statistic is defined as
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uted with q + m - 1 degrees of freedom. Here
is the weighted residual sum of squares. See [5] for details.
The PLW statistic for the probe-set  is then defined as
The LMW and PLW methods are implemented in the R
package plw [30] available at the authors' web page and at
the Bioconductor projects web page [31] (at the time of
writing only among devel-packages, bioconductor 2.2).
Parameter estimation
The q × q covariance matrix ∑z of the reduced model in
Equ. 3 is divided according to
where ∑A is the covariance matrix for all but the last
dimension of zp and  is the variance of the last dimen-
sion (indexes A and B refer to the corresponding sub-
matrices of the transformation matrix M in Equ. 2). The
reduced model is fitted in two steps. First the parameters
m, β and the sub-matrix ∑A are estimated by dropping the
last dimension of the vectors zp. Since the reduced model
is not identifiable without a restriction on the function ν
or the covariance matrices ∑z we use the restriction
trace(∑A) = q - 1. Secondly, the parameters m and β are
held fixed and ∑z is estimated using the complete zp vec-
tors. Temporarily the assumption of no regulated genes is
used (δp = 0 for all probes) and ∑z is estimated under the
restriction that the trace of the ∑A part should be equal to
q - 1.
In step 1, we let xp denote the sub-vector of zp obtained by
dropping the last element. Under the reduced model xp is
distributed according to the model in Equ. 1 with ∑ = ∑A,
μp = 0, n = q - 1, and using the EM-algorithm an iterative
procedure for estimating m, β and ∑A is obtained. Given
estimates of the previous iteration, m0, β0 and ∑A0,
updated estimates are found as follows. Let
The updated estimate of ∑A is
and the updated estimate of β is found by numerical max-
imization of the function
With  equal to the updated estimate of β let
where  is the digamma function. The
updated estimate of m is then found using numerical max-
imization of the function
f(m) = m (log(m) + S) -2 log (Γ(m/2)). (10)
In step 2 a similar iterative procedure is used to estimate
∑z. With ∑z0 denoting the estimate of ∑z from the previous
iteration and with wp re-defined as
where  and  are the estimates obtained in step 1, an
updated estimate of ∑z is computed according to Equ. 8
with zp replacing xp. In order for the estimators of ∑A and
∑z, in step 1 and 2, respectively, to comply with the trace
restriction the updated estimates are scaled at the end of
each iteration. [For more details see Additional file 1]
Data sets
The two data sets used in Figures 1 and 2 are publicly
available at the Gene Expression Omnibus repository [32]
with series or sample reference number indicated below.
Data set A consists of the 18 arrays from the severe group
of the COPD data set [33] (series reference number
GSE1650), where Affymetrix arrays of type HG U133A
t p
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where selected from a lung tumor data set [34] (sample
reference numbers GSM47958-GSM47976, excluding
GSM47967). Here the HG-U95A arrays were used.
Five spike-in data sets were used to evaluate the proposed
methods. In the Affymetrix U95 and 133A Latin Square
data sets [35] arrays of type HG-U95A and HG-U133A,
respectively, were used. The Affymetrix U95 data set con-
sists of data from 59 arrays divided into 19 groups of size
3, and one group of size 2.
From the 20 groups there are 178 possible pair-wise group
comparisons each with 16 [36] known differentially
expressed genes among the 12626 genes present on the
arrays. The Affymetrix 133A data set comprise data from
42 arrays with a total of 22300 probe-sets of which 42
were spiked in at known concentration. The 42 arrays are
divided into 14 groups of size 3 and thus there are 91 pos-
sible pair-wise group comparisons. As done in the Affy-
comp II assessments [36] we exclude 271 probe-sets
which are likely to cross-hybridize to spike-in probe-sets.
The sequence of each spike-in clone was blasted against all
HG-U133A target sequences (~600 bp regions from which
probes are selected). A threshold of 100 bp identified 271
probe-sets which are available in the Affycomp R-package.
From the Gene Logic Tonsil and AML data sets [37] all
groups with 3 replicated arrays were used, giving a total of
12 and 10 groups, respectively. For these data there are 11
genes spiked in at known concentration, which can be
studied in 66 and 45 pair-wise group comparisons, respec-
tively. Both data sets were obtained using the Affymetrix
HG-U95A arrays having 12626 genes.
The Golden Spike data set [38] consists of 6 arrays of type
Drosgenome1 divided into 2 groups of equal size. The
samples used in this experiment consist of mRNA from
3866 genes, of which 1331 are differentially expressed
between the groups. The Drosgenome1 array has a total of
14010 genes, thus 10144 of these should not be
expressed, 2535 should be expressed but not regulated,
and 1331 should be expressed and regulated.
Since all 1331 genes are up-regulated in the spike-in group
it is necessary to take special care in the normalization
when analyzing this data set. Generally this means per-
forming normalizations based on a subset of genes, either
only the 2535 genes spiked in at identical concentration
in both groups [39], or the 2535 genes together with the
10144 absent genes [38]. Thus, knowledge about which
genes are regulated, which of course is not available for a
real situation, is used in the normalization.
For PPLR, BGX, and the analysis based on MAS5 expres-
sion indexes we used a loess-subset normalization of
probe set summaries as done in [17,19,38]. For the analy-
sis based on RMA (and GCRMA) pre-processed data we
used a loess-subset normalization of PM probe intensities
similar to the one performed in [40]. PM probe intensities
were corrected for background using the default back-
ground method of RMA (or GCRMA) and then loess-nor-
malized using the same subset as used in [38], thus the
2535 genes spiked in at identical concentration in both
groups together with the 10144 absent genes. At this point
PLW, median-t, and combined-p were applied to logged
PM intensities. Probe set summaries using median polish
were then computed and all 10 methods using expression
indexes as input were used to rank genes with respect to
differential expression.
Comparison with existing methods
Using the spike-in data sets listed above the proposed
methods, PLW and LMW were compared with 14 existing
methods for ranking genes. The 14 methods include rank-
ing with respect to: observed fold change (FC), ordinary t-
test, the moderated t-test in the R-package LIMMA [3], the
weighted moderated t-test in the R-package WAME.EM
[8], Efron's penalized t-test [11] and the Shrink-t method
[9] in the R-package st, the SAM method [10] in the R-
package samr, the Local-pooled-error test [13] in the R-
package LPE, the Intensity-Based Moderated T-statistic
(IBMT) [6] using the R-code available at http://
eh3.uc.edu/r/ibmtR.R, and the two probe-level methods
median-t and combined-p suggested by Hess and Iyer
[40].
All methods using expression indexes as input (including
PLW) were applied to RMA, GCRMA and MAS5 expres-
sion indexes obtained using the R-package affy, while
PLW, median-t, and combined-p were applied to logged
PM intensities, background corrected and normalized
using the default methods of RMA and GCRMA. (The
empirical Bayes approach of GCRMA was used to calcu-
late background corrected intensities, thus the fast option
was set to FALSE). With LMW 4–6 spline-knots (depend-
ing on the number of probe-sets) were used for the func-
tion ν, whereas 12 knots were used in PLW (the spline-
knots are set using an internal function in the R-package
plw). Note that RMA and GCRMA were applied only to
the arrays involved in each group comparison, as opposed
to running RMA and GCRMA using all arrays of each data
set.
We also compared with the PPLR method [19] applied to
the expression index and probe-level measurement error
of the multi-mgMOS model [18] available in the R-pack-
age puma, the logit-t procedure implemented in the R-
package plw according to the description in [41], and thePage 6 of 11
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The R-code used for each of the 14 methods is available as
supplementary material. [See Additional file 2]
Due to long computer run times the comparison with the
BGX method is restricted to the Golden Spike data set, and
a subset of genes from the Gene Logic AML data set (the
run time for one single analysis of 6 arrays with all 12626
probe-sets is more than 24 hours). The subset of size 1011
of the Gene Logic AML data set consists of probe-sets
number 6000–7002 (excluding 6030, 6367, and 6463)
together with the 11 spiked probe-sets and the same sub-
set was used in [17]. The probe-set numbering is as
obtained when loading data into R using the R-package
affy. Also, to avoid introducing yet another normalization
of the Golden Spike data set, logit-T was not applied to
this data set.
For each spike-in data set and combination of method
and expression index/pre-processing ROC-curves were
calculated. Also, for the analysis using a complete set of
probe-sets, the area (AUC) under the ROC curve up to 25,
50, 100 and 200 false positives was computed. In the
comparison with BGX using only 1011 probe-sets, AUC
was computed up to 2, 4, 8 and 16 false positives in order
to cover the same false positive range as for the complete
probe-set comparisons.
For the analysis based on RMA pre-processing, ROC
curves for a subset of the compared methods are found in
Figure 3. AUC values up to 100 false positives from the
complete probe-set analysis are found in Tables 1 and 2.
(ROC curves for all methods and AUC up to 25, 50, 200
false positives are available as supplementary material.
[See Additional file 3 and Additional file 4])
Results for RMA pre-processing are found in the upper
part of Table 1. Three of the four methods taking the vari-
ability-to-intensity-level dependency into account (PLW,
LMW and LPE) performed overall better than the other
methods, with the proposed method PLW having the
highest AUC on four of the five data sets. The fourth
ROC curvesFigure 3
ROC curves. ROC curves for a subset of the methods compared when applied to RMA pre-processed data. The horizontal 
axis shows the number of false positives (FP) and the vertical axis the proportion of true positives found (TP).
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ency into account (IBMT) performed comparably well on
the Affymetrix and Golden Spike data sets but less so on
the two Gene Logic data sets.
Ranking genes with respect to FC performs quite well on
the Affymetrix U133A and the two Gene Logic data sets
but not on the other two data sets. Among the penalized
and moderated t-test methods, WAME and Efron-t con-
sistently perform better than the other ones. However, the
difference between these methods for the two Affymetrix
Latin Square and the Golden Spike data sets are small,
compared to the difference in AUC obtained using the
two Gene Logic data sets. Thus, the two Gene Logic data
sets appear slightly different from the other three.
The results obtained using GCRMA in the lower part of
Table 1 are very similar to the results with RMA shown in
the upper part. For the Golden Spike data set, replacing
GCRMA with RMA improves the performance of all meth-
ods but the ordering of the methods is fairly unchanged.
Overall, IBMT, Efron-t and median-t, performs slightly
better when applied to GCRMA expression indexes
whereas WAME and LPE performs slightly worse. The
overall ordering of the top-two methods is unchanged.
Since MAS5 expression indexes show a very clear depend-
ency between variability and intensity level in Figure 1,
and since the variability decreases with intensity it comes
as no surprise that all three methods taking this depend-
ency into account consistently performs better than all
other methods as shown in the upper part of Table 2. The
LMW method has the most accurate ranking of genes in 4
out of the 5 data-sets, and performs better than the IBMT
method on all 5 data-sets. Since the main difference
between LMW and IBMT is that LMW performs a weighted
analysis, and since WAME overall performs better than
LIMMA, it appears as if weighted analysis should be used
in preference to analysis using unweighted analysis.
The lower part of Table 2 shows results for PPLR, BGX,
and logit-t. For the Golden spike data set both PPLR and
BGX perform comparably well, only LMW and IBMT
applied on MAS5 expression indexes have higher ROC
curve AUC. In the analysis of 1011 probe sets from the
Gene Logic AML data set, PLW shows consistently higher
true positive rate compared with BGX (Figure 3) and the
Table 1: Area under ROC curves up to 100 false positives, RMA and GCRMA
Method Pre-processing Affymetrix U95 Affymetrix 133A Golden Spike Gene Logic Tonsil Gene Logic AML
PLW RMA 96(1) 93(6) 42(1) 87(1) 86(1)
LMW RMA 96(2) 94(1) 36(5) 84(3) 80(5)
LPE RMA 94(7) 93(11) 40(2) 84(2) 85(2)
combined-p RMA 95(4) 92(12) 39(3) 83(4) 81(4)
WAME RMA 95(5) 94(2) 33(7) 81(7) 78(8)
median-t RMA 95(3) 93(10) 39(4) 82(6) 80(6)
IBMT RMA 95(6) 94(3) 34(6) 78(9) 76(9)
Efron-t RMA 94(8) 93(4) 32(8) 79(8) 79(7)
FC RMA 92(12) 93(5) 29(12) 83(5) 85(3)
LIMMA RMA 94(9) 93(7) 32(9) 76(10) 75(10)
SAM RMA 94(10) 93(8) 32(11) 74(12) 74(11)
Shrink-t RMA 94(11) 93(9) 32(10) 75(11) 73(12)
t-test RMA 85(13) 86(13) 21(13) 57(13) 52(13)
PLW GCRMA 97(1) 92(8) 54(1) 87(1) 87(1)
LMW GCRMA 95(3) 93(1) 50(5) 84(3) 79(6)
median-t GCRMA 96(2) 92(10) 50(2) 83(4) 81(5)
combined-p GCRMA 95(5) 91(12) 50(4) 86(2) 81(4)
LPE GCRMA 95(6) 91(11) 50(3) 82(6) 86(2)
IBMT GCRMA 95(4) 93(2) 47(6) 81(9) 76(8)
Efron-t GCRMA 94(7) 93(4) 37(8) 82(7) 79(7)
WAME GCRMA 94(10) 93(3) 39(7) 83(5) 75(10)
FC GCRMA 93(12) 93(7) 30(13) 81(8) 86(3)
LIMMA GCRMA 94(9) 93(5) 37(9) 80(10) 73(11)
SAM GCRMA 94(8) 93(6) 36(11) 79(11) 76(9)
Shrink-t GCRMA 94(11) 92(9) 37(10) 78(12) 70(12)
t-test GCRMA 86(13) 84(13) 30(12) 64(13) 53(13)
Area under ROC curves up to 100 false positives rounded to nearest integer value with an optimum of 100. Numbers within parenthesis are within 
data set ranks for the methods compared (separately for RMA and GCRMA). Methods are ordered with respect to mean rank across the five data 
sets. Results in the upper and lower part are based on RMA and GCRMA pre-processed data, respectively.Page 8 of 11
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100) is 84 and 75 for PLW and BGX, respectively. For the
remaining data sets PPLR performed comparably well
with other methods using MAS5 expression indexes, but
less so when comparing with RMA and GCRMA pre-proc-
essed data.
The second proposed method LMW differs from existing
moderated and penalized t-test in that the global variance
estimator (which gene-specific estimators are adjusted
towards) varies with intensity-level.
Actually this is the only difference between LMW and the
WAME method. The LPE method also uses a global vari-
ance estimator that varies with intensity-level. But
opposed to using a weighted mean of the global and gene-
specific estimator, only the global estimator is used in the
denominator of the LPE statistic. Thus for genes with sim-
ilar intensity-level, LPE is basically identical to ranking
using fold change. Hence, since LMW consistently per-
forms better than WAME, and LPE has higher AUC than
fold change in four of the five data test, modeling the glo-
bal variance estimator as a function of intensity is worth-
while doing.
Figure 2 shows that the false positive rate obtained by
adjusting towards a global estimate that varies with inten-
sity-level results in a much more stable false positive rates
compared to using a (truly) global estimate. It should be
mentioned that as the number of arrays increases, the var-
iability of the false positive rate across intensity-level
decreases, when adjusting towards a truly global estimate
as well as when adjusting towards an intensity-level
dependent global estimate. Figure 2 is based on 3+3
arrays, and the estimated false positive rate for LIMMA
varies between 1.3% and 8.3%. When repeating the same
analysis using 5+5 arrays the estimated false positive rate
varied between 1.8% and 7%.
With RMA (and GCRMA) pre-processed data, we do com-
parisons between 1) Compute probe set summaries from
probe intensities and then do inference, and 2) Do infer-
ence for each PM probe and then summarize into one
score. Thus, the summarization (here done using median-
polish) is considered as a part of the first approach. PLW
and median-t use the second approach, whereas LMW and
the ordinary t-test are the corresponding methods using
the first approach. From the results presented here the sec-
ond approach appears a better option. This was also
shown by Hess and Iyer in [40] where they propose the
median-t and combined-p method.
Approach 1 could also include a second normalization of
probe set summaries. However, neither of the two
approaches can be given information about which genes
that are regulated without making the comparison biased.
Thus, in the analysis of the Golden Spike data set, a sec-
ond subset-loess normalization of probe set summaries as
done in [38] can not be used when comparing approach
1 and 2. We therefore used a subset-loess normalization of
PM probe intensities in a similar way as done in [40].
Table 2: Area under ROC curves up to 100 false positives, MAS5, PPLR, BGX, and Logit-T
Method Pre-processing Affymetrix U95 Affymetrix 133A Golden Spike Gene Logic Tonsil Gene Logic AML
LMW MAS5 89(1) 87(1) 60(1) 79(1) 70(2)
IBMT MAS5 87(2) 87(2) 59(2) 77(3) 69(3)
LPE MAS5 84(3) 84(3) 57(3) 78(2) 79(1)
WAME MAS5 71(6) 81(5) 34(5) 69(4) 54(8)
SAM MAS5 74(4) 81(4) 11(8) 67(5) 54(9)
LIMMA MAS5 71(7) 81(6) 31(6) 67(6) 54(6)
Shrink-t MAS5 71(8) 80(7) 23(7) 67(7) 54(7)
t-test MAS5 73(5) 76(8) 39(4) 60(9) 47(10)
Efron-t MAS5 65(9) 72(9) 3(9) 66(8) 57(4)
FC MAS5 56(10) 61(10) 0(10) 58(10) 55(5)
BGX - - 58 - 75*
logit-T 94 92 - 80 79
PPLR multi-mgMOS 88 90 57 71 69
# of genes 12626 22029 14010 12626 12626
# of spikes 16 42 1331 11 11
# of groups 20 14 2 12 10
Area under ROC curves up to 100 false positives rounded to nearest integer value with an optimum of 100. Numbers within parenthesis are within 
data set ranks for the methods compared, and methods are ordered with respect to mean rank across the five data sets (within MAS5 only). 
*Results in italic are from the subset of 1011 probe sets of the Gene Logic AML data set.Page 9 of 11
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set using subset-loess normalized MAS5 expression
indexes as done by Choe et al. in [38]. They show that, for
a large set of different pre-processing methods, a second
loess-subset normalization of probe-set summaries has a
large effect (Figure 7a). They give no direct answer to
whether a subset-based probe normalization to the same
extent improves the performance of the corresponding
normalization using all probes. Therefore, to present
comparable results only, we have separated results from
these two types of subset-normalizations using knowl-
edge about which genes are regulated. Thus, for the
Golden Spike data set, we mainly compare BGX and PPLR
with the analysis based on MAS5 expression indexes, and
the results from RMA and GCRMA pre-processed data is
mainly compared separately.
More complicated models often come with the prize of
longer computer run times. Of the methods evaluated the
BGX model and the PPLR method together with the
multi-mgMOS model are the most computer intense
ones. The computer run time for one single two group
analysis of 3+3 HG-U95A arrays with data from 12626
genes is more than 24 hours with BGX and 1.5 hours for
PPLR+multi-mgMOS (using the recommended EM
method of PPLR) on a 2.2 GHz AMD Opteron machine.
The corresponding time (including pre-processing of PM
and MM data) is 2–3 minutes for PLW and 9 seconds for
the moderated t-test in LIMMA.
Conclusion
We have presented two new methods for ranking genes
with respect to differential expression: Probe level Locally
moderated Weighted median-t (PLW) and Locally Moder-
ated Weighted-t (LMW). Both methods perform very well
compared to existing methods with PLW having the most
accurate ranking of regulated genes in four out of five
examined spike-in data sets with RMA and GCRMA proc-
essed data. With LMW we show that introducing an inten-
sity-level dependent scale parameter for the prior
distribution of the gene-specific variances improves the
performance of the moderated t-test. Also, compared to
the moderated t-statistic, LMW shows a much more stable
false positive rate across intensity-levels when used on
MAS5 expression indexes. In the PLW method inference is
performed directly on logged PM intensities and the
median of the resulting moderated t-statistics for each
probe-set is used to find differentially expressed genes.
Overall the PLW method performs better than all com-
pared methods and thus probe-level inference appears to
be preferable over the standard approach using gene
expression indexes for inference.
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